Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2015 | 11-2014 | 07-2014 | 04-2014 | 01-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 792 | 431 | 578 | 952 | 29 |
| Receivables | 35 | 75 | 99 | 100 | 131 |
| Inventories | 78 | 19 | N/A | N/A | N/A |
| Other current assets | 0 | 1,400 | 0 | 0 | 0 |
| TOTAL | $1,158 | $2,198 | $1,201 | $1,467 | $165 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 3,322 | 3,371 | 3,395 |
| Investments And Advances | 53 | 53 | 43 | N/A | N/A |
| TOTAL | $53 | $53 | $3,366 | $3,371 | $3,395 |
| Total Assets | $1,211 | $2,251 | $4,566 | $4,838 | $3,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 806 | 910 | 1,285 |
| Accounts payable and accrued liabilities | 36 | 109 | 150 | 134 | 186 |
| Other current liabilities | N/A | 678 | N/A | N/A | N/A |
| TOTAL | $38 | $789 | $957 | $1,046 | $1,473 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -27 | -46 | 59 | 59 | 59 |
| TOTAL | $0 | $0 | $59 | $59 | $59 |
| Total Liabilities | $38 | $789 | $1,017 | $1,105 | $1,533 |
| Shareholders' Equity | |||||
| Common Shares | 35 | 34 | 33 | 32 | 17 |
| Retained earnings | -9,103 | -8,663 | -6,229 | -5,653 | -5,160 |
| TOTAL | $1,145 | $1,416 | $3,550 | $3,733 | $2,027 |
| Total Liabilities And Equity | $1,183 | $2,205 | $4,566 | $4,838 | $3,560 |